[
  {
    "ts": null,
    "headline": "Moderna, Inc. (MRNA) Down 35% YTD. Here Is Why",
    "summary": "Moderna, Inc. (NASDAQ:MRNA) is among the 13 Best S&P 500 Stocks to Buy According to Wall Street Analysts, based on upside potential. However, 2025 has been a challenging year for the company, with a year-to-date decline of over 35% in its share price. The biotechnology firm made a name for itself by timely developing an […]",
    "url": "https://finnhub.io/api/news?id=17f4e6c81875ca6e1ccf42fcdf6c54de058d799715fb82020780090a96682a3e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756016252,
      "headline": "Moderna, Inc. (MRNA) Down 35% YTD. Here Is Why",
      "id": 136502940,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna, Inc. (NASDAQ:MRNA) is among the 13 Best S&P 500 Stocks to Buy According to Wall Street Analysts, based on upside potential. However, 2025 has been a challenging year for the company, with a year-to-date decline of over 35% in its share price. The biotechnology firm made a name for itself by timely developing an […]",
      "url": "https://finnhub.io/api/news?id=17f4e6c81875ca6e1ccf42fcdf6c54de058d799715fb82020780090a96682a3e"
    }
  }
]